These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3891943)

  • 1. Degenerative neurologic disease in patients formerly treated with human growth hormone. Report of the Committee on Growth Hormone Use of the Lawson Wilkins Pediatric Endocrine Society, May 1985.
    J Pediatr; 1985 Jul; 107(1):10-2. PubMed ID: 3891943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathologic verification of Creutzfeldt-Jakob disease in the exhumed American recipient of human pituitary growth hormone: epidemiologic and pathogenetic implications.
    Tintner R; Brown P; Hedley-Whyte ET; Rappaport EB; Piccardo CP; Gajdusek DC
    Neurology; 1986 Jul; 36(7):932-6. PubMed ID: 3520381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary growth hormone and Creutzfeldt-Jakob disease.
    Norrby E
    Acta Paediatr Scand Suppl; 1986; 325():116-24. PubMed ID: 3296633
    [No Abstract]   [Full Text] [Related]  

  • 4. Creutzfeldt-Jakob disease following pituitary-derived human growth hormone therapy: a new American case.
    Marzewski DJ; Towfighi J; Harrington MG; Merril CR; Brown P
    Neurology; 1988 Jul; 38(7):1131-3. PubMed ID: 3290703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiologic survey of patients treated with growth hormone in France in the period 1959-1990: preliminary results.
    Job JC; Maillard F; Goujard J
    Horm Res; 1992; 38 Suppl 1():35-43. PubMed ID: 1295811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status report on the US human growth hormone recipient follow-up study.
    Mills JL; Fradkin J; Schonberger L; Gunn W; Thomson RA; Piper J; Wysowski D; Brown P
    Horm Res; 1990; 33(2-4):116-9; discussion 120. PubMed ID: 2210615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Creutzfeldt-Jakob disease discovered at autopsy in a human growth hormone recipient.
    New MI; Brown P; Temeck JW; Owens C; Hedley-Whyte ET; Richardson EP
    Neurology; 1988 Jul; 38(7):1133-4. PubMed ID: 3290704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new case of Creutzfeldt-Jakob disease associated with human growth hormone therapy in New Zealand.
    Croxson M; Brown P; Synek B; Harrington MG; Frith R; Clover G; Wilson J; Gajdusek DC
    Neurology; 1988 Jul; 38(7):1128-30. PubMed ID: 3290702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contaminated material caused Creutzfeld-Jakob disease (CJD) in some undersized children who were treated with growth hormone (GH).
    Stockdale T
    Nutr Health; 2000; 14(2):141-2. PubMed ID: 10904939
    [No Abstract]   [Full Text] [Related]  

  • 10. Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom.
    Buchanan CR; Preece MA; Milner RD
    BMJ; 1991 Apr; 302(6780):824-8. PubMed ID: 2025705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human growth hormone and Creutzfeldt-Jakob disease.
    Zekauskas S; Boggs MB; Wilson DP
    J Okla State Med Assoc; 1990 Sep; 83(9):447-8. PubMed ID: 2280278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The decline and fall of Creutzfeldt-Jakob disease associated with human growth hormone therapy.
    Brown P
    Neurology; 1988 Jul; 38(7):1135-7. PubMed ID: 3290705
    [No Abstract]   [Full Text] [Related]  

  • 13. Distinct pathological phenotypes of Creutzfeldt-Jakob disease in recipients of prion-contaminated growth hormone.
    Cali I; Miller CJ; Parisi JE; Geschwind MD; Gambetti P; Schonberger LB
    Acta Neuropathol Commun; 2015 Jun; 3():37. PubMed ID: 26108478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower risk of Creutzfeldt-Jakob disease in pituitary growth hormone recipients initiating treatment after 1977.
    Abrams JY; Schonberger LB; Belay ED; Maddox RA; Leschek EW; Mills JL; Wysowski DK; Fradkin JE
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1666-9. PubMed ID: 21816775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Untoward events in patients treated with growth hormone in the USA.
    Hintz RL
    Horm Res; 1992; 38 Suppl 1():44-9. PubMed ID: 1295812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States.
    Fradkin JE; Schonberger LB; Mills JL; Gunn WJ; Piper JM; Wysowski DK; Thomson R; Durako S; Brown P
    JAMA; 1991 Feb; 265(7):880-4. PubMed ID: 1992185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A further British case of growth hormone induced Creutzfeldt-Jakob disease.
    Ellis CJ; Katifi H; Weller RO
    J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1200-2. PubMed ID: 1479400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.
    Grumbach MM; Bin-Abbas BS; Kaplan SL
    Horm Res; 1998; 49 Suppl 2():41-57. PubMed ID: 9730672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A patient with Creutzfeldt-Jakob disease following treatment with human growth hormone].
    Roos RA; Wintzen AR; Will RG; Ironside JW; van Duinen SG
    Ned Tijdschr Geneeskd; 1996 Jun; 140(22):1190-3. PubMed ID: 8692356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biological aspects of Creutzfeldt-Jakob disease related to the extractive growth hormone].
    Deslys JP
    Pathol Biol (Paris); 1995 Feb; 43(2):97-103. PubMed ID: 7777386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.